Yoshio Ijiri - Concepedia

Author

Yoshio Ijiri

Osaka University of Pharmaceutical Sciences ORCID

Also Known As

Ikumi YOSHIO, Y Ijiri, Y. Ijiri, YOSHIO IJIRI, Yoshio IJIRI, Yoshio Ijiri

Publications

833

Citations

H-Index

Concepts

All Affiliations

Osaka University of Pharmaceutical Sciences Osaka Medical and Pharmaceutical University Osaka Ohtani University Osaka City University Shirasagi Hospital

About

Yoshio Ijiri is an author at Osaka University of Pharmaceutical Sciences specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	502
2	Engineering	3	3	46
3	Health Sciences	2	2	36
4	Natural Sciences	1	1	34
5	Public Health	1	1	28

Yoshio Ijiri

Publications

683

Citations

H-Index

Page 1

	Year	Citations
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats Yuka Shimeda, Yoshihiko Hirotani, Youko Akimoto, Biological and Pharmaceutical Bulletin InflammationKidney GlutathioneCisplatin-induced NephrotoxicityMedicineLipid Peroxidation	2005	138
Protective Effects of Lactoferrin against Intestinal Mucosal Damage Induced by Lipopolysaccharide in Human Intestinal Caco-2 Cells Yoshihiko Hirotani, Kenji Ikeda, Ryuji Kato, YAKUGAKU ZASSHI InflammationAnti-inflammatoryIndirect EvidenceImmunotoxicologyMucosal Immunology	2008	76
Effects of Capsaicin on Cellular Damage and Monolayer Permeability in Human Intestinal Caco-2 Cells Yuri Tsukura, M Mori, Yoshihiko Hirotani, Biological and Pharmaceutical Bulletin	2007	39
Interaction of platinum agents, cisplatin, carboplatin and oxaliplatin against albumin <i>in vivo</i> rats and <i>in vitro</i> study using inductively coupled plasma‐mass spectrometory Ryuji Kato, Takaji Sato, Asuka Iwamoto, Biopharmaceutics & Drug Disposition Platinum AgentsBiological Mass SpectrometryPlasma‐mass SpectrometoryMolecular PharmacologyBioanalysis	2019	34
Dialyzability of the Antiepileptic Drug Zonisamide in Patients Undergoing Hemodialysis Yoshio Ijiri, Toru Inoue, Fumio Fukuda, Epilepsia	2004	30
Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia Hideki Imano, Ryuji Kato, Shota Tanikawa, Journal of Pharmacological Sciences Cardiovascular PharmacologyFactor Xa InhibitionPharmacotherapyOxidative StressObstructive Sleep Apnea	2018	28
The 2-Hydroxyiminostilbene Metabolite of Carbamazepine or the Supernatant from Incubation of Hepatocytes with Carbamazepine Activates Inflammasomes: Implications for Carbamazepine-Induced Hypersensitivity Reactions Ryuji Kato, Yoshio Ijiri, Tetsuya Hayashi, Drug Metabolism and Disposition	2019	27
Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction Ryuji Kato, Yoshio Ijiri, Tetsuya Hayashi, The Journal of Toxicological Sciences Gefitinib Activates InflammasomesInflammatory Lung DiseaseInflammasome ActivationImmunologyImmunotherapeutics	2020	26
Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity Jun Moriguchi, Ryuji Kato, Machiko Nakagawa, European Journal of Pharmacology Intestinal P-glycoprotein ExpressionBiochemistryMedicineGlycobiologyGastroenterology	2007	25
Hydrogen gas attenuates embryonic gene expression and prevents left ventricular remodeling induced by intermittent hypoxia in cardiomyopathic hamsters Ryuji Kato, Atsuo Nomura, Aiji Sakamoto, American Journal of Physiology-Heart and Circulatory Physiology	2014	24

Page 1